Dmitry Samarsky

Corporate Officer/Principal at

UMass Chan Medical School

59 year

80 connections

Health Technology

Consumer Services

Commercial Services

Profile

Dmitry Samarsky is currently a Member at UMass Chan Medical School and an Advisory Board Member at RusBioVentures LLC.
Previously, he held positions such as Director-Technology Development at Dharmacon, Inc. from 2005 to 2007, Manager-Business Development at Invitrogen Corp.
from 2003 to 2005, Vice President-Technology Development at Galena Biopharma, Inc. from 2007 to 2011, Principal at Sequitur, Inc. from 2001 to 2003, and Principal at Howard Hughes Medical Institute, Inc. from 1998 to 2001.
He also served as Senior VP-International Business Development at Guangzhou Ribobio Co., Ltd. from 2011 to 2015.
Dr. Samarsky has a doctorate degree from the University of Massachusetts, which he obtained in 1998, and an undergraduate degree from Lviv University.

Dmitry Samarsky active positions

Companies	Position	Start
UMass Chan Medical School UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
RusBioVentures LLC RusBioVentures LLC Investment ManagersFinance RBV Capital invests in companies located across the globe primarily in Russia. The fund targets companies operating in the fields of biopharmaceuticals, biomedical technology, bioinformatics, healthcare IT, and medical device industries. It provides financing for seed, early and later stage capital requirements and also makes co investments.	Consultant / Advisor	-

All active positions of Dmitry Samarsky

Former positions of Dmitry Samarsky

Companies	Position	End
SIRNAOMICS LTD.	Chief Tech/Sci/R&D Officer	02/01/2023
Guangzhou Ribobio Co., Ltd.	Corporate Officer/Principal	01/01/2015
Galena Biopharma, Inc. Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical products through biopharmaceutical research and development	Chief Tech/Sci/R&D Officer	01/01/2011
Dharmacon, Inc. Dharmacon, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes new technology for RNA oligonucleotide synthesis	Corporate Officer/Principal	-
Invitrogen Corp. Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and sells life science research kits and provides research services	Corporate Officer/Principal	01/01/2005

See the detail of Dmitry Samarsky's experience

Training of Dmitry Samarsky

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Dmitry Samarsky's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	13
Invitrogen Corp. Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and sells life science research kits and provides research services	Electronic Technology
Galena Biopharma, Inc. Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical products through biopharmaceutical research and development	Health Technology
Sequitur, Inc. Sequitur, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and disease research services	Commercial Services
Dharmacon, Inc. Dharmacon, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes new technology for RNA oligonucleotide synthesis	Commercial Services
Howard Hughes Medical Institute, Inc. Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment	Miscellaneous
University of Massachusetts University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
UMass Chan Medical School UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Lviv University Lviv University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Guangzhou Ribobio Co., Ltd.
RusBioVentures LLC RusBioVentures LLC Investment ManagersFinance RBV Capital invests in companies located across the globe primarily in Russia. The fund targets companies operating in the fields of biopharmaceuticals, biomedical technology, bioinformatics, healthcare IT, and medical device industries. It provides financing for seed, early and later stage capital requirements and also makes co investments.	Finance
OliX Pharmaceuticals, Inc. OliX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs against locally treatable diseases	Health Technology
Silence Therapeutics GmbH Silence Therapeutics GmbH BiotechnologyHealth Technology Operates biotechnology company to develops RNAi-based drugs	Health Technology
Sirnaomics Ltd. Sirnaomics Ltd. BiotechnologyHealth Technology Develops therapeutics for treatment of cancer and fibrosis diseases	Health Technology